These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32634266)

  • 21. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Comparison of Inflammation-Based Prognostic Scores in Patients With Extrahepatic Bile Duct Cancer After Pancreaticoduodenectomy.
    Fujiwara Y; Haruki K; Shiba H; Hamura R; Shirai Y; Furukawa K; Gocho T; Yanaga K
    J Surg Res; 2019 Jun; 238():102-112. PubMed ID: 30769246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.
    Jing CY; Fu YP; Shen HJ; Zheng SS; Lin JJ; Yi Y; Huang JL; Xu X; Zhang J; Zhou J; Fan J; Ren ZG; Qiu SJ; Zhang BH
    Oncotarget; 2017 Feb; 8(8):13293-13303. PubMed ID: 28076328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
    Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
    Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
    World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma.
    Asakura R; Yanagimoto H; Ajiki T; Tsugawa D; Mizumoto T; So S; Urade T; Nanno Y; Fukushima K; Gon H; Komatsu S; Kuramitsu K; Goto T; Asari S; Kido M; Toyama H; Fukumoto T
    Dig Surg; 2022; 39(2-3):65-74. PubMed ID: 35051946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma.
    Oshiro Y; Sasaki R; Fukunaga K; Kondo T; Oda T; Takahashi H; Ohkohchi N
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):389-95. PubMed ID: 23138964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
    Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
    Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?
    Hakeem AR; Marangoni G; Chapman SJ; Young RS; Nair A; Hidalgo EL; Toogood GJ; Wyatt JI; Lodge PA; Prasad KR
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1047-54. PubMed ID: 25051217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
    Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
    J Surg Oncol; 2020 Dec; 122(7):1516-1517. PubMed ID: 32960983
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
    Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
    Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis.
    Gong ZJ; Cheng JW; Gao PT; Huang A; Sun YF; Zhou KQ; Hu B; Qiu SJ; Zhou J; Fan J; Yang XR
    Oncologist; 2019 Jul; 24(7):997-1007. PubMed ID: 30910867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
    Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
    Harada N; Yoshizumi T; Yamashita YI; Soejima Y; Ikegami T; Harimoto N; Itoh S; Maehara Y
    Anticancer Res; 2017 Jul; 37(7):3763-3769. PubMed ID: 28668872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
    Si A; Li J; Yang Z; Xia Y; Yang T; Lei Z; Cheng Z; Pawlik TM; Lau WY; Shen F
    Ann Surg Oncol; 2019 Jun; 26(6):1841-1850. PubMed ID: 30843164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.